Posted in | News | Display

CommScope Unveils New Nano Amplifier Under Signal Vision Subscriber Drop Product Line

With the growing demand for DOCSIS 3.0 high-speed data services, high definition television (HDTV) programming and a requirement to reduce size and costs, many cable operators desire the convenience of having amplification in a Nano-compact housing. To help meet this demand, CommScope has introduced a new Nano amplifier to the Signal Vision line of subscriber drop products.

The Signal Vision Nano amplifier is the smallest of its kind in the industry, allowing for ease of installation in even the most constrained locations as well as in compact network interface device (NID) boxes. With 15 dB of gain in the forward path and a passive reverse path, this amplifier supports the technologies needed to drive today’s high-speed voice, video and data networks. Designed in a Nano-compact aluminum plated housing with brass F-ports, this product meets or exceeds all SCTE requirements as well as the harsh demands of an outside plant environment.

“CommScope continuously leverages advances in technology to enhance products and solutions for our customers,” said Neil Phillips, vice president, Signal Vision. “These advances to our Signal Vision product portfolio have made it possible for us to offer a reduced size amplifier to improve ease of installation without sacrificing performance.”

CommScope will display its new Nano amplifier, as well other solutions for the cable industry, at the SCTE Cable-Tec Expo in Denver, Colorado on October 28-30 at booth #7089.

Signal Vision is a registered trademark of CommScope, Inc.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.